Dr. Paul Finger has been named one of America’s top doctors in 2017. Castle Connolly’s top doctors are nominated by their peers through an extensive survey process of thousands of American physicians. Each year, Castle Connolly receives nearly 100,000 nominations through this process. The organization’s research team screens medical education, training, board certifications, hospital appointments, [..] Read More…
When it comes to your children’s health, trust your instincts! The persistence of an Oklahoma mother likely saved her daughter’s life. When Kourtney Norton noticed her daughter McKinley was walking sideways, she knew something wasn’t right. So, Kourtney took McKinley to her pediatrician. He mistakenly thought the little girl had an eye infection. When McKinley [..] Read More…
Last fall, The Eye Cancer Foundation hosted a retinoblastoma workshop in Guangzhou, China. The primary goal was to deliver systematic training in retinoblastoma management based on the general principles of the origin and development of the disease. But the workshop went beyond practical training. It served to build strong relationships among all of the participants. [..] Read More…
Memorial Day weekend is right around the corner. The holiday traditionally kicks off the summer season. That means boating out on the lake, lazy days at the beach, yard work, and long road trips. As you get ready for all of your summer activities, you’ll probably run by the store and pick up some sunscreen [..] Read More…
Radiation plaque therapy is the most common treatment for melanoma inside the eye. This eye and vision sparing treatment utilizes a metallic plaque, sometime called a “radiation implant” or “radioactive source.” The doctor surgically implants the plaque on the wall of the eye, covering the base of the intraocular tumor. The implant remains in place [..] Read More…
A new study by Dr. Sonal Chaugule and Dr. Paul Finger has identified a promising treatment for patients diagnosed with iris melanoma. This is a first study describing regression characteristics in published literature. Uveal melanoma is the most common primary intraocular malignancy in adults. Iris melanoma is the rarest cancer in this family, making up [..] Read More…
Lulu was less than 2 months old when doctors in China diagnosed her with retinoblastoma. When doctors located tumors in her eyes, they scheduled her to have her eyes removed that afternoon. But her parents, who are both blind, were determined to do everything in their power to save their daughter’s eyes. “My husband and [..] Read More…
A recent study published in the British Journal of Ophthalmology by Dr. Richard Kaplan, Dr. Sonal S Chaugule, and Dr. Paul Finger introduces a new treatment option for patients with radiation macular degeneration that no can no longer be controlled with maximum, standard anti-VEGF medication. Radiation macular degeneration is the most common cause of permanent [..] Read More…
The Second Eye Cancer Working Day, hosted by The Eye Cancer Foundation, International Society of Ocular Oncology, and American Joint committee on Cancer took place on March 24th, 2017 at International Convention Center, Sydney, Australia. The working day provided a unique opportunity for eye cancer specialists from around the world to work together, face-to-face. The [..] Read More…
Led by its chair Dr. Paul Finger, The Ophthalmic Oncology Task Force (OOTF) is building a foundation of multicenter, international consensus guidelines to allow for better communication and patient care. Along with the AJCC and the Union for International Cancer Control (UICC), the American Brachytherapy Society (ABS), The American Association of Physicists in Medicine (AAPM), [..] Read More…
"Very well treated by Dr. Finger. He explained everything I needed to know about my issue with detail and attention, putting me at ease and giving me confidence to handle this problem for the rest of my life.”
– N.N.
